Association between preschool eczema and medication for attention-deficit/hyperactivity disorder in school age

Pediatric Allergy and Immunology

Volumn 28, Issue 1, 2017, Pages 44-50

  Johansson, Emma Kristin ^a,b   Ballardini, Natalia ^a,b,c   Kull, Inger ^a   Bergström, Anna ^a   Wahlgren, Carl Fredrik ^a,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

adolescent; atopic dermatitis; attention deficit hyperactivity disorder; child; depression; epilepsy; migraine

Indexed keywords

ANTIDEPRESSANT AGENT; ANTICONVULSIVE AGENT;

ADOLESCENT; ANXIETY DISORDER; ARTICLE; ATOPIC DERMATITIS; ATTENTION DEFICIT DISORDER; CHILD; COHORT ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; DISEASE REGISTRY; ECZEMA; ENVIRONMENTAL FACTOR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; OUTCOME ASSESSMENT; PARENTAL SMOKING; PHOBIA; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; SOCIAL STATUS; SWEDISH CITIZEN; DRUG UTILIZATION; INFANT; POPULATION; PRESCHOOL CHILD; REGISTER; STATISTICS AND NUMERICAL DATA; SWEDEN;

ADOLESCENT; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD, PRESCHOOL; DRUG UTILIZATION; ECZEMA; FEMALE; HUMANS; INFANT; MALE; POPULATION; REGISTRIES; SWEDEN;

EID: 84998962603     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/pai.12657     Document Type: Article

References (30)

1. Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004: 113: 832–6.
2. Bieber T. Atopic dermatitis. N Engl J Med 2008: 358: 1483–94.
3. Williams HC. Clinical practice Atopic dermatitis. N Eng J Med 2005: 352: 2314–24.
4. van der Hulst AE, Klip H, Brand PL. Risk of developing asthma in young children with atopic eczema: a systematic review. J Allergy Clin Immunol 2007: 120: 565–9.
5. Spergel JM, Paller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003: 112: S118–27.
6. Ballardini N, Bergstrom A, Bohme M, et al. Infantile eczema: prognosis and risk of asthma and rhinitis in preadolescence. J Allergy Clin Immunol 2014: 133: 594–6.
7. Schmitt J, Buske-Kirschbaum A, Roessner V. Is atopic disease a risk factor for attention-deficit/hyperactivity disorder? A systematic review Allergy 2010: 65: 1506–24.
8. Yaghmaie P, Koudelka CW, Simpson EL. Mental health comorbidity in patients with atopic dermatitis. J Allergy Clin Immunol 2013: 131: 428–33.
9. Chen MH, Su TP, Chen YS, et al. Is atopy in early childhood a risk factor for ADHD and ASD? a longitudinal study. J Psychosom Res 2014: 77: 316–21.
10. Genuneit J, Braig S, Brandt S, et al. Infant atopic eczema and subsequent attention-deficit/hyperactivity disorder–a prospective birth cohort study. Pediatr Allergy Immunol 2014: 25: 51–6.
11. Garg N, Silverberg JI. Association between childhood allergic disease, psychological comorbidity, and injury requiring medical attention. Ann Allergy Asthma Immunol 2014: 112: 525–32.
12. Yu SH, Silverberg JI. Association between Atopic Dermatitis and Depression in US Adults. J Invest Dermatol 2015: 135: 3183–6.
13. Silverberg JI, Joks R, Durkin HG. Allergic disease is associated with epilepsy in childhood: a US population-based study. Allergy 2014: 69: 95–103.
14. Chen MH, Wu YH, Su TP, et al. Risk of epilepsy among patients with atopic dermatitis: a nationwide longitudinal study. Epilepsia 2014: 55: 1307–12.
15. Buske-Kirschbaum A, Schmitt J, Plessow F, Romanos M, Weidinger S, Roessner V. Psychoendocrine and psychoneuroimmunological mechanisms in the comorbidity of atopic eczema and attention deficit/hyperactivity disorder. Psychoneuroendocrinology 2013: 38: 12–23.
16. Holmberg K, Lundholm C, Anckarsater H, Larsson H, Almqvist C. Impact of asthma medication and familial factors on the association between childhood asthma and attention-deficit/hyperactivity disorder: a combined twin- and register-based study: epidemiology of allergic disease. Clin Exp Allergy 2015: 45: 964–73.
17. Tsai JD, Chang SN, Mou CH, Sung FC, Lue KH. Association between atopic diseases and attention-deficit/hyperactivity disorder in childhood: a population-based case-control study. Ann Epidemiol 2013: 23: 185–8.
18. Mogensen N, Larsson H, Lundholm C, Almqvist C. Association between childhood asthma and ADHD symptoms in adolescence–a prospective population-based twin study. Allergy 2011: 66: 1224–30.
19. Blackman JA, Gurka MJ, Gurka KK, Oliver MN. Emotional, developmental and behavioural co-morbidities of children with chronic health conditions. J Paediatr Child Health 2011: 47: 742–7.
20. Romanos M, Gerlach M, Warnke A, Schmitt J. Association of attention-deficit/hyperactivity disorder and atopic eczema modified by sleep disturbance in a large population-based sample. J Epidemiol Community Health 2010: 64: 269–73.
21. Thomas R, Sanders S, Doust J, Beller E, Glasziou P. Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics 2015: 135: e994–1001.
22. Giacobini M, Medin E, Ahnemark E, Russo LJ, Carlqvist P. Prevalence, patient characteristics, and pharmacological treatment of children, adolescents, and adults diagnosed with ADHD in Sweden. J Atten Disord 2014: pii: 1087054714554617.
23. Wickman M, Kull I, Pershagen G, Nordvall SL. The BAMSE project: presentation of a prospective longitudinal birth cohort study. Pediatr Allergy Immunol 2002: 13(Suppl 15): 11–3.
24. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 2009: 24: 659–67.
25. Wettermark B, Hammar N, Fored CM, et al. The new Swedish prescribed drug register–opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 2007: 16: 726–35.
26. Saval P, Fuglsang G, Madsen C, Osterballe O. Prevalence of atopic disease among Danish school children. Pediatr Allergy Immunol 1993: 4: 117–22.
27. Deckert S, Kopkow C, Schmitt J. Nonallergic comorbidities of atopic eczema: an overview of systematic reviews. Allergy 2014: 69: 37–45.
28. Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol 2009: 124: 1251–8 e23.
29. Simpson EL. Comorbidity in atopic dermatitis. Curr Dermatol Rep 2012: 1: 29–38.
30. Wedgeworth E, Powell AM, Flohr C. Incidence of cancer in the context of atopic dermatitis. Br J Dermatol 2011: 164: 896–7; authors’ reply 97–8.